Clovis Oncology reported $13.23M in Stock for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Acadia Pharmaceuticals ACAD:US $ 6.33M 0.68M
Anika Therapeutics ANIK:US 35.34M 111K
Clovis Oncology CLVS:US $ 13.23M 1.27M
Eli Lilly And LLY:US $ 3899.4M 6.4M
Esperion Therapeutics ESPR:US $ 29.23M 6.42M
GlaxoSmithKline GSK:LN 4664M 1339M
Halozyme Therapeutics HALO:US $ 47.76M 6.15M
Heron Therapeutics HRTX:US $ 56.47M 8.09M
Intrexon XON:US $ 12.73M 0.53M
Neurocrine Biosciences NBIX:US $ 29.3M 0.3M
Novartis NOVN:VX SF 6880M 117M
Puma Biotechnology PBYI:US $ 6.66M 0.61M
Rigel Pharmaceuticals RIGL:US $ 6.22M 0.55M
Seattle Genetics SGEN:US $ 319.35M 43.61M
Ultragenyx Pharmaceutical RARE:US $ 21.08M 3.27M
Veracyte VCYT:US $ 14.6M 2.23M
YTE INCY:US $ 54.5M 19.05M